+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2014-2023

  • ID: 4771044
  • Report
  • April 2019
  • Region: Global
  • 144 pages
  • MarketLine
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
Pharmaceuticals Top 5 Emerging Markets Industry Guide 2014-2023

Summary

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the emerging five pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
  • These countries contributed $222.4 billion to the global pharmaceuticals industry in 2018, with a compound annual growth rate (CAGR) of 7.7% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $369.3 billion in 2023, with a CAGR of 10.7% over the 2018-23 period.
  • Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $132.9 billion in 2018. This was followed by India and Brazil with a value of $38.2 and $23.6 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $234.7 billion in 2023, followed by India and Brazil with expected values of $72.7 and $27.9 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to buy
  • What was the size of the emerging five pharmaceuticals market by value in 2018?
  • What will be the size of the emerging five pharmaceuticals market in 2023?
  • What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five pharmaceuticals market?
Note: Product cover images may vary from those shown
2 of 2
  • Introduction
  • What is this report about?
  • Who is the target reader?
  • How to use this report
  • Definitions
  • Top 5 Emerging Countries Pharmaceuticals
  • Industry Outlook
  • Pharmaceuticals in South Africa
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Brazil
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in China
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in India
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Mexico
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Company Profiles
  • Leading Companies
  • Appendix
  • Methodology
List Of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2014-23
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2014-18
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2018-23
Table 4: South Africa pharmaceuticals market value: $ billion, 2014-18
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2018
Table 6: South Africa pharmaceuticals market share: % share, by value, 2018
Table 7: South Africa pharmaceuticals market value forecast: $ billion, 2018-23
Table 8: South Africa size of population (million), 2014-18
Table 9: South Africa gdp (constant 2005 prices, $ billion), 2014-18
Table 10: South Africa gdp (current prices, $ billion), 2014-18
Table 11: South Africa inflation, 2014-18
Table 12: South Africa consumer price index (absolute), 2014-18
Table 13: South Africa exchange rate, 2014-18
Table 14: Brazil pharmaceuticals market value: $ billion, 2014-18
Table 15: Brazil pharmaceuticals market geography segmentation: $ billion, 2018
Table 16: Brazil pharmaceuticals market share: % share, by value, 2018
Table 17: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Table 18: Brazil size of population (million), 2014-18
Table 19: Brazil gdp (constant 2005 prices, $ billion), 2014-18
Table 20: Brazil gdp (current prices, $ billion), 2014-18
Table 21: Brazil inflation, 2014-18
Table 22: Brazil consumer price index (absolute), 2014-18
Table 23: Brazil exchange rate, 2014-18
Table 24: China pharmaceuticals market value: $ billion, 2014-18
Table 25: China pharmaceuticals market geography segmentation: $ billion, 2018
Table 26: China pharmaceuticals market share: % share, by value, 2018
Table 27: China pharmaceuticals market value forecast: $ billion, 2018-23
Table 28: China size of population (million), 2014-18
Table 29: China gdp (constant 2005 prices, $ billion), 2014-18
Table 30: China gdp (current prices, $ billion), 2014-18
Table 31: China inflation, 2014-18
Table 32: China consumer price index (absolute), 2014-18
Table 33: China exchange rate, 2014-18
Table 34: India pharmaceuticals market value: $ billion, 2014-18
Table 35: India pharmaceuticals market geography segmentation: $ billion, 2018
Table 36: India pharmaceuticals market share: % share, by value, 2018
Table 37: India pharmaceuticals market value forecast: $ billion, 2018-23
Table 38: India size of population (million), 2014-18
Table 39: India gdp (constant 2005 prices, $ billion), 2014-18
Table 40: India gdp (current prices, $ billion), 2014-18
Table 41: India inflation, 2014-18
Table 42: India consumer price index (absolute), 2014-18
Table 43: India exchange rate, 2014-18
Table 44: Mexico pharmaceuticals market value: $ billion, 2014-18
Table 45: Mexico pharmaceuticals market geography segmentation: $ billion, 2018
Table 46: Mexico pharmaceuticals market share: % share, by value, 2018
Table 47: Mexico pharmaceuticals market value forecast: $ billion, 2018-23
Table 48: Mexico size of population (million), 2014-18
Table 49: Mexico gdp (constant 2005 prices, $ billion), 2014-18
Table 50: Mexico gdp (current prices, $ billion), 2014-18
Table 51: Mexico inflation, 2014-18
Table 52: Mexico consumer price index (absolute), 2014-18
Table 53: Mexico exchange rate, 2014-18
Table 54: Adcock Ingram Holdings Ltd: key facts
Table 55: Adcock Ingram Holdings Ltd: key financials ($)
Table 56: Adcock Ingram Holdings Ltd: key financials (ZAR)
Table 57: Adcock Ingram Holdings Ltd: key financial ratios
Table 58: Aspen Pharmacare Holdings Ltd: key facts
Table 59: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 60: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

List of Figures
Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2014-23
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2014-18
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2018-23
Figure 4: South Africa pharmaceuticals market value: $ billion, 2014-18
Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 6: South Africa pharmaceuticals market share: % share, by value, 2018
Figure 7: South Africa pharmaceuticals market value forecast: $ billion, 2018-23
Figure 8: Forces driving competition in the pharmaceuticals market in South Africa, 2018
Figure 9: Drivers of buyer power in the pharmaceuticals market in South Africa, 2018
Figure 10: Drivers of supplier power in the pharmaceuticals market in South Africa, 2018
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2018
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2018
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2018
Figure 14: Brazil pharmaceuticals market value: $ billion, 2014-18
Figure 15: Brazil pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 16: Brazil pharmaceuticals market share: % share, by value, 2018
Figure 17: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Figure 18: Forces driving competition in the pharmaceuticals market in Brazil, 2018
Figure 19: Drivers of buyer power in the pharmaceuticals market in Brazil, 2018
Figure 20: Drivers of supplier power in the pharmaceuticals market in Brazil, 2018
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2018
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2018
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2018
Figure 24: China pharmaceuticals market value: $ billion, 2014-18
Figure 25: China pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 26: China pharmaceuticals market share: % share, by value, 2018
Figure 27: China pharmaceuticals market value forecast: $ billion, 2018-23
Figure 28: Forces driving competition in the pharmaceuticals market in China, 2018
Figure 29: Drivers of buyer power in the pharmaceuticals market in China, 2018
Figure 30: Drivers of supplier power in the pharmaceuticals market in China, 2018
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2018
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2018
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in China, 2018
Figure 34: India pharmaceuticals market value: $ billion, 2014-18
Figure 35: India pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 36: India pharmaceuticals market share: % share, by value, 2018
Figure 37: India pharmaceuticals market value forecast: $ billion, 2018-23
Figure 38: Forces driving competition in the pharmaceuticals market in India, 2018
Figure 39: Drivers of buyer power in the pharmaceuticals market in India, 2018
Figure 40: Drivers of supplier power in the pharmaceuticals market in India, 2018
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2018
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2018
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in India, 2018
Figure 44: Mexico pharmaceuticals market value: $ billion, 2014-18
Figure 45: Mexico pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 46: Mexico pharmaceuticals market share: % share, by value, 2018
Figure 47: Mexico pharmaceuticals market value forecast: $ billion, 2018-23
Figure 48: Forces driving competition in the pharmaceuticals market in Mexico, 2018
Figure 49: Drivers of buyer power in the pharmaceuticals market in Mexico, 2018
Figure 50: Drivers of supplier power in the pharmaceuticals market in Mexico, 2018
Figure 51: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2018
Figure 52: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2018
Figure 53: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2018
Figure 54: Adcock Ingram Holdings Ltd: revenues & profitability
Figure 55: Adcock Ingram Holdings Ltd: assets & liabilities
Figure 56: Aspen Pharmacare Holdings Ltd: revenues & profitability
Figure 57: Aspen Pharmacare Holdings Ltd: assets & liabilities
Figure 58: Sanofi SA: revenues & profitability
Figure 59: Sanofi SA: assets & liabilities
Figure 60: Shanghai Pharmaceuticals: revenues & profitability
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll